Which is why I keep going back to the time when the big money already arriving here 3 years ago decided to jump back out...in the spring of 2014 when the Focalin disappointing news hit.
It's not like they'll never come back...but we had them and were trading millions of dollars in liquidity and then the FDA came along and slammed IPCI's generics pipeline door shut for past 2 and half years until recently re-opening it with the tentative SeroquelXR approval and 2 of PAR's profit sharing with IPCI FocalinXR strengths now launched.
The gamble right now is do people believe the FDA is going to accept IPCI's Rexista NDA and grant them their Rexista PDUFA date...and will that decision be immediately followed by a lucrative Rexista partnership announcement?
If that occurs I remain adamant that that will be the biggest PR this company has ever put out since inception and will finally put IPCI back on big money radars.
News 
Market Data 
Discover 
AI
